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Candidate genes associated with the heritable humoral response to Mycobacterium 1 
avium subspecies paratuberculosis in dairy cows have factors in common with 2 
gastrointestinal diseases in humansBy McGovern et al. XXXX. Paratuberculosis in cattle, 3 
also commonly known as Johne’s disease causes serious performance, and by extension, 4 
economic losses on farms. Its tentative links with Crohn’s disease in humans is also of concern. 5 
The present study revealed that breeding for differences in humoral response to 6 
paratuberculosis in cattle is possible should routine access to test results be available and also 7 
that the underlying genetic variants contributing to this genetic variation have indeed factors in 8 
common with gastrointestinal diseases in humans 9 
 10 
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Infection of cattle with bovine paratuberculosis (i.e., Johne’s disease) is caused by 36 
Mycobacterium avium subspecies paratuberculosis (MAP) and results in a chronic incurable 37 
gastroenteritis. This disease, which has economic ramifications for the cattle industry, is 38 
increasing in detected prevalence globally; subclinically infected animals can silently shed the 39 
bacterium into the environment for years, exposing contemporaries and hampering disease 40 
control programs. The objective of the present study was to firstly quantify the genetic 41 
parameters for humoral response to MAP in dairy cattle. This was followed by a genome-based 42 
association analysis and subsequent downstream bioinformatic analyses from imputed whole 43 
genome sequence single nucleotide polymorphism (SNP) data. After edits, ELISA test records 44 
were available on 136,767 cows; analyses were also undertaken on a subset of 33,818 of these 45 
animals from herds with at least 5 MAP ELISA positive cows, with at least 1 of those positive 46 
cows being homebred. Variance components were estimated using univariate animal and sire 47 
linear mixed models. The heritability calculated from the animal model for humoral response 48 
to MAP using alternative phenotype definitions varied from 0.02 (SE=0.003) to 0.05 49 
(SE=0.008). The genome-based associations were undertaken within a mixed model 50 
framework using weighted deregressed estimated breeding values as a dependent variable on 51 
1,883 phenotyped animals that were ≥87.5% Holstein-Friesian. Putative susceptibility 52 
quantitative trait loci (QTLs) were identified on BTA 1, 3, 5, 6, 8, 9, 10, 11, 13, 14, 18, 21, 23, 53 
25, 26, 27 and 29; mapping the most significant SNPs to genes within and overlapping these 54 
QTLs revealed that the most significant associations were with the 10 functional candidate 55 
genes KALRN, ZBTB20, LPP, SLA2, FI3A1, LRCH3, DNAJC6, ZDHHC14, SNX1 and HAS2. 56 
Pathway analysis failed to reveal significantly enriched biological pathways, when both 57 
bovine-specific pathway data and human ortholog data were taken in to account. The existence 58 
of genetic variation for MAP susceptibility in a large dataset of dairy cows signifies the 59 
potential of breeding programs for reducing MAP susceptibility. Furthermore, the 60 
identification of susceptible QTLs facilitates greater biological understanding of bovine 61 
paratuberculosis and potential therapeutic targets for future investigation. The novel molecular 62 
similarities identified between bovine paratuberculosis and human inflammatory bowel disease 63 
suggest potential for human therapeutic interventions to be translated to veterinary medicine, 64 
and vice versa. 65 
 66 
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Paratuberculosis, also known as Johne’s disease, caused by the gram-positive aerobic 70 
bacterium Mycobacterium avium subspecies paratuberculosis (MAP), is a contagious disease 71 
primarily affecting ruminants. Paratuberculosis results in chronic, progressive gastroenteritis 72 
for which there is no cure (Harris and Barletta, 2001). First reported in Europe by Johne and 73 
Frothingham (1895) as a “peculiar case of tuberculosis in cattle”, MAP is primarily spread via 74 
the fecal-oral route; younger animals are most susceptible to clinical MAP infection upon 75 
exposure (Windsor and Whittington, 2009). Clinical signs of MAP infection in cattle, primarily 76 
observed in older cattle (MAP has an incubation period of up to 10 years; Collins, 2003) include 77 
weight loss due to characteristic pipestream diarrhea, hypoproteinemia (Sweeney et al., 2012), 78 
reduced milk yield (Richardson and More, 2009) and reduced cull cow value (Richardson and 79 
More, 2009), all of which adversely impact both animal well-being and farm profitability. 80 
Infected animals silently shed MAP in their environment via contaminated faeces, spreading 81 
paratuberculosis to uninfected animals (Koets et al., 2015). 82 
Testing for MAP infection, concurrent with management (including measures to 83 
address both biocontainment and bioexclusion at herd level) and vaccination strategies, are the 84 
advocated control measures used to curtail the spread of bovine paratuberculosis. 85 
Unfortunately, all of these have limited efficacy and will not guarantee eradication, even at 86 
herd level, despite continued effort over an extended period. Correctly classifying animals as 87 
infected with paratuberculosis is challenging due to the available tests being suboptimal in both 88 
sensitivity and specificity; moreover, vaccination does not result in a reduction in the number 89 
of infected animals or offer long-term immunity (Park and Yoo, 2016, Geraghty et al., 2014). 90 
In addition, vaccination against MAP is prohibited in some countries (e.g., the Republic of 91 
Ireland). Previous studies on the contribution of genetic variability to paratuberculosis in dairy 92 
cattle suggest heritability estimates of susceptibility to the disease ranging from <0.01 (Koets 93 
et al., 1999) to 0.283 (Küpper et al., 2012). Differences in parameter estimates among studies 94 
could be due to a multitude of reasons, including the extent of variability (residual and genetic) 95 
in the populations sampled, sample sizes, trait definition, and models used (i.e., linear, 96 
threshold, animal, sire). Nonetheless, the non-zero heritability estimates of MAP susceptibility, 97 
coupled with the existence of considerable genetic variability, suggest that genetic selection 98 
could improve resistance to MAP infection in the bovine population; this could prove useful in 99 




Prior studies based on genome-wide associations (Settles et al., 2009, Pant et al., 2010, 102 
Alpay et al., 2014) have identified multiple different loci putatively associated with bovine 103 
paratuberculosis. The degree of concordance in reported quantitative trait loci (QTL) across 104 
studies is, however, poor. Only one study exists that used imputed whole genome SNP data to 105 
detect loci associated with MAP infection in cattle, although the study was based on relatively 106 
small cohorts of up to 459 dairy cattle (Kiser et al., 2017). Kiser et al. (2017) identified loci on 107 
chromosomes 3, 8, 10, 12, 14, 16, 21 and 22 associated with paratuberculosis susceptibility. 108 
Three studies exist that have used a gene-set enrichment analysis approach following a 109 
genome-based association analysis to investigate modest-effect SNPs and genes, enriched 110 
pathways and gene ontologies associated with MAP infection in cattle (Neibergs et al., 2010; 111 
Del Corvo et al., 2017; Kiser et al., 2017). 112 
The objective of the present study was to quantify the genetic parameters of the humoral 113 
response to MAP infection in a large cohort of Irish dairy cows; the derived parameters were 114 
subsequently used to estimate breeding values as an input variable for an association analyses 115 
using imputed whole genome single nucleotide polymorphism (SNP) data to detect regions of 116 
the bovine genome putatively associated with humoral response to MAP. The biology 117 
underpinning the detected regions was further investigated by conducting bioinformatics 118 
analyses to identify the underlying gene functions and related biochemical pathways. 119 
 120 
MATERIALS AND METHODS 121 
The data used in the present study were obtained from a pre-existing database managed by the 122 
Irish Cattle Breeding Federation (ICBF). Therefore, it was not necessary to obtain animal care 123 
and use committee approval in advance of conducting this study. 124 
 125 
Data 126 
A total of 663,719 enzyme-linked immunosorbent assay (ELISA) test records on humoral 127 
(blood and milk antibody) response to MAP were available from 9 Irish laboratories between 128 
June 2012 and November 2017 inclusive on 282,396 cows in 2,704 dairy and beef herds. The 129 
health status of these herds for other diseases was unknown. Only cows aged between 2 and 12 130 
years at the time of testing were considered. Records classified as “inconclusive” (n = 3,639), 131 
“suspect” (n = 1,406) or “low positive” (n = 4,210) were not considered further; subsequently, 132 
all individual cow test records were classified as either “positive” (13,685 records) or 133 
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“negative” (640,779 records) to MAP infection based on the respective test manufacturer’s 134 
guidelines (Bovine ELISA Paratuberculosis Antibody Screening Kit (Institut Pourquier, 135 
France), ID Screen Paratuberculosis Indirect Screening Test (ID Vet, Montpellier, France, 136 
Mycobacterium paratuberculosis Antibody Test Kit PARACHEK (Prionics, Zurich, 137 
Switzerland) and Paratuberculosis Antibody Screening Test (Idexx Laboratories, Westbrook, 138 
ME, USA)). 139 
Of the 10,137 cows with at least 1 positive ELISA record, 2,651 also had a negative 140 
MAP result following a positive MAP result; these cows were discarded from the dataset. Only 141 
data from dairy herds were considered further. A herd was classified as beef or dairy based on 142 
the average breed composition of the cows, as per Twomey et al. (2016). Cow breed 143 
composition was determined from the recorded breed composition of ancestors. A dairy herd 144 
was defined as a herd whose average dairy breed proportion of the cows was ≥75%. Only herd-145 
years with ≥25 cows tested were retained. Following these edits, 612,375 test records from 146 
260,740 cows in 4,543 herd-years from 2,170 herds remained. 147 
Herd-years defined as MAP naïve were those which only had MAP negative cattle 148 
residing in them; these herd-years were not considered further, leaving a total of 378,701 149 
records from 186,174 cows in 2,485 herd-years (1,487 herds). The remaining herd-years were 150 
considered exposed to MAP infection, as they had at least one cow that yielded an ELISA 151 
positive result. To be retained, all cows must have calved at least once in the herd prior to being 152 
tested in the positive herd-year. All cow inter-location movement data were available from the 153 
ICBF’s database as it is a legal requirement to record these movements in Ireland. A cow was 154 
considered exposed to MAP if she resided in an exposed herd-year for at least one year prior 155 
to an ELISA test. This was to allow MAP-negative cows adequate time to become exposed to 156 
MAP via infected contemporary(ies). 157 
Cow parity at test was categorized as 1, 2, 3, 4, or ≥5. Stage of lactation (i.e., days in 158 
milk) at ELISA test was categorized into 9 categories: 10 – 49, 50 – 99, ….. , 400 – 450; cows 159 
<10 or >450 days in milk at test were not considered further. Cows with no sire information 160 
were discarded and only the most recent test result per cow was considered further. Following 161 
these edits, 155,072 cows remained. General heterosis and recombination loss coefficients for 162 






𝑖𝑖=1 , respectively, 163 
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where sirei and dami are the proportion of breed i in the sire and dam, respectively (VanRaden 164 
and Sanders, 2003). 165 
Contemporary groups were defined as herd-year-season of test using an algorithm 166 
described in detail by Berry and Evans (2014). The algorithm clusters herd-contemporaries that 167 
were tested around the same period of the year together but within no more than 90 days of 168 
each other. Only contemporaries groups with at least 5 cows and which had at least one positive 169 
and one negative MAP test result were retained. After edits, the final dataset comprised of 170 
136,767 cows from 2,463 herd-years with test records reported from 8 different laboratories. 171 
 172 
Genetic parameter estimation and genetic evaluation 173 
Variance components for humoral response to MAP were estimated using animal and sire 174 
linear mixed models in ASReml (Gilmour et al., 2009). The fitted linear mixed model was: 175 
Y = CG +heterosis + recombination + parity × stage of lactation + a + e 176 
where Y is the binary dependent variable of the MAP phenotype, CG is the fixed effect of 177 
contemporary group, heterosis is the fixed effect of a general heterosis coefficient (0.0%, >0.0 178 
to <0.1%, ≥0.1 to <0.2%, …, ≥0.9 to <100%, 100%), recombination is the fixed effect of a 179 
general recombination loss coefficient (0.00%, >0.00 to <0.05%, ≥0.05 to <0.10%, …, ≥0.45 180 
to <0.50%, 0.50%, >0.50%), parity is the fixed effect of the parity of the cow, stage of lactation 181 
is the fixed effect of stage of lactation, a is the random additive genetic effect of the animal 182 
where a ~ N(0, A 𝜎𝜎a2) with 𝜎𝜎a2 representing the additive genetic variance of the animal and A 183 
as the additive genetic relationship matrix among animals, and e is the random residual effect 184 
where e ~ N(0, I 𝜎𝜎𝑒𝑒2) with 𝜎𝜎𝑒𝑒2 representing the residual variance, and I representing the identity 185 
matrix. Each cow’s pedigree was traced back to the founder population, which was assigned to 186 
one of 10 genetic groups. Sire models used were as described above except that the direct 187 
animal genetic effect was replaced by a sire genetic effect. 188 
Genetic parameters were calculated for the overall dataset of 136,767 cows but also 189 
within each of the 8 laboratories separately. Genetic parameters were also estimated for 190 
humoral response to MAP where the data was restricted to 33,818 cows that resided in herd-191 
years that contained at least 5 MAP ELISA positive cows, with at least 1 of those positive cows 192 
being homebred. The observed binary-scale heritability estimates were transformed to the 193 
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underlying liability scale via the formula of Robertson and Lerner (1949), using the average 194 
MAP prevalence of the respective cohort: 195 




where ℎ𝐿𝐿2 = heritability on the liability scale (i.e., threshold model), ℎ𝑂𝑂2  = heritability on the 197 
observed scale, p = the trait prevalence/100, and z2 = the height of the ordinate of normal 198 
distribution corresponding to a truncation point applied to p. 199 
Two genetic evaluations were conducted for the present study, the first for validating 200 
estimated breeding values (EBVs) and the second for subsequent use in the genome-wide 201 
association analyses. Estimated breeding values and their corresponding reliabilities for MAP 202 
susceptibility were calculated using the MiX99 software suite (Stranden and Lidauer, 1999) 203 
with the fitted animal model being the same as previously described. EBVs were estimated for 204 
the set of 33,818 phenotyped cows and their relatives that resided in herd-years that contained 205 
at least 5 MAP positive cows, with at least 1 of those positive cows being homebred. 206 
Validation of EBVs 207 
For the purposes of validation of the genetic evaluations, the MAP phenotype of a sub-cohort 208 
of the 33,818 cows was masked and their breeding values estimated via their pedigree links 209 
with related phenotyped animals. The validation dataset was chosen based on herd-year 210 
characteristics in that only herd-years with at least 20 phenotyped animals and a mean herd 211 
incidence of between 10 and 25% were retained. In total, 6,600 animals from 94 herds were 212 
considered in the validation; the mean prevalence of ELISA positivity in this cohort was 15%. 213 
Once the MAP phenotypes were masked, a genetic evaluation was undertaken using the 214 
phenotypes of all remaining 27,218 animals. The EBVs of the validation animals with an 215 
estimated reliability of >0.05 were retained; 5,477 animals remained. Within herd-year, the 216 
validation animals were stratified equally (where the modular of 3 per herd was 0, otherwise 217 
as close to equal as possible) into high EBV (poor), average EBV and low EBV (good) groups. 218 
Logistic regression was used to model the association between EBV stratum (n=3) and the logit 219 
of the probability of a positive MAP outcome; a binomial distribution of errors was assumed. 220 
The area under the receiver operating curve (ROC) was estimated and the odds of a positive 221 
outcome calculated from the model solutions; the low EBV group was used as the referent 222 
category. A further logistic regression analysis was undertaken where the fixed effects model 223 
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terms of herd-year, heterosis, recombination and a two-way interaction between parity and 224 
stage of lactation were also fitted. 225 
 226 
Whole-genome sequence imputation and association analysis 227 
Of the 433,989 animals with an EBV from the genetic evaluation (with no masked 228 
phenotypes), only genotyped animals ≥87.5% Holstein-Friesian were considered for the 229 
genome-wide analysis; principal component analysis of the genotypes (along with animals 230 
from other breeds) was used to ensure all animals were Holstein-Friesian. A total of 8,780 231 
animals remained. The EBVs estimated for the Holstein-Friesian animals were deregressed 232 
using the Secant method in MiX99 (Strandén and Mäntysaari, 2010), and subsequently, 233 
effective record contributions (ERCs) were calculated for each animal. Only the subset of 1,883 234 
genotyped animals (662 male, 1,221 female) that had an ERC value ≥1 were considered further. 235 
These animals were initially genotyped using one of 7 Illumina arrays, namely 3k (2,909 SNPs, 236 
n = 36), LD (7,931 SNPs, n = 230), Bovine SNP50 (54,001 SNPs, n = 300), International Dairy 237 
and Beef version 1 (IDBv1) (17,137 SNPs, n = 121), IDBv2 (18,004 SNPs, n = 677), IDBv3 238 
(53,450 SNPs, n = 236) and HD (777,962, n = 283). All animals had a call rate ≥ 90% and only 239 
autosomal SNPs, SNPs with a reported position as on UMDv3.1, and SNPs with a call rate ≥ 240 
90% were retained within each panel. 241 
All animals were imputed to HD using a two-step approach with FImpute2 software 242 
(Sargolzaei et al., 2014); this involved imputing the IDB, LD and 3k genotyped animals to the 243 
Bovine50 beadchip density (i.e., 54,001 SNPs) and consequently imputing all resulting 244 
genotypes (including the Bovine50 Beadchip genotypes) to HD using a multi-breed reference 245 
population of 5,504 HD-genotyped animals. The genotypes of all animals were imputed to 246 
whole-genome sequence level using a reference population of 2,333 Bos taurus animals (using 247 
multiple breeds) from Run6.0 of the 1,000 Bulls Genomes Project (Daetwyler et al., 2014). A 248 
consensus SNP density across all animals was achieved using SAMtools version 1.3.1  (Li, 249 
2011), followed by Beagle software version 4.1 imputation (Browning and Browning, 2016) 250 
to call variants in the reference population and improve genotype calls. Details surrounding the 251 
alignment to UMDv3.1, variant calling and quality controls conducted on the reference 252 
population are described by (Daetwyler et al., 2014). A total of 41.39 million SNP variants 253 
were called with an average coverage of 12.85X. The imputation procedure was completed by 254 
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initially using Eagle v2.3.2 (Loh et al., 2016) to phase imputed HD genotypes, followed by 255 
imputation to whole-genome sequence level using minimac3 (Das et al., 2016). 256 
Regions of poor WGS imputation accuracy perhaps due to local mis-assemblies or mis-257 
orientated contigs, were identified using an additional dataset of 147,309 verified parent-258 
progeny relationships. Mendelian errors, defined as the proportion of opposing homozygotes 259 
in a parent-progeny pair, were estimated for each relationship and the subsequent Mendelian 260 
error rate per SNP was determined. To accurately identify genomic regions of poor imputation, 261 
the R package GenWin (Beissinger et al., 2015) which fits a β-spline to the data to find likely 262 
inflection points, was used to determine genomic region breakpoints of high Mendelian errors. 263 
Windows were analysed using an initial window size of 5 kb and Genwin pooled windows for 264 
which the SNP Mendelian error rate were similar. The average SNP Mendelian error rate per 265 
window was estimated and all variants within windows where the mean SNP Mendelian error 266 
rate was >0.02 were removed (687,137 SNPs were removed). 267 
A genomic relationship matrix, using just the autosomal high density SNP genotypes, 268 
was constructed among animals using the VanRaden method 1 (VanRaden, 2008). Association 269 
analyses were undertaken for each SNP separately using linear mixed models in WOMBAT 270 
(Meyer, 2007), to calculate SNP effects for all 1,883 animals. The model fitted for each SNP 271 
analysis was: 272 
Deregressed EBV = µ + SNP + a + e 273 
where deregressed EBV is the dependent variable, µ is the fixed effect of the population 274 
mean, SNP is the fixed effect of allele dosage for each SNP (coded as 0, 1, or 2),  a is the 275 
random effect of the animal, where a ~ N(0, G 𝜎𝜎𝑎𝑎2) with 𝜎𝜎𝑎𝑎2 representing the additive genetic 276 
variance of the animal and G is the genomic relationship matrix among animals; e represents 277 
the residual, where e ~ N(0, I 𝜎𝜎𝑒𝑒2) with 𝜎𝜎𝑒𝑒2 representing the residual variance and I represents 278 
the identity matrix. The dependent variable was weighted using the formula by Garrick et al. 279 
(2009): 280 
𝑤𝑤𝑖𝑖 =  
1 − ℎ2







where 𝑤𝑤𝑖𝑖 =  is the weighting factor of the deregressed EBV of the ith animal, h2 is the 282 
heritability estimate (i.e., h2 = 0.05 as estimated in the present study), 𝑟𝑟𝑖𝑖2 is the reliability of the 283 
deregressed EBV for the ith animal, and c is the genetic variance not accounted for by the SNPs 284 
(i.e., c = 0.90). Test statistics for all SNPs were obtained and SNPs with a p-value of ≤5 × 10-285 
8 were considered to be genome-wide significant. 286 
Defining QTLs 287 
Genome-wide significant SNPs (p-value ≤5 × 10-8) informed the initial positions for QTL 288 
regions associated with humoral response to MAP. The QTL start and end positions were 289 
defined based on SNPs that were in strong linkage disequilibrium (LD) with these significantly 290 
associated SNPs. An r2 threshold value of ≥0.7 was utilized to define whether or not SNPs were 291 
in strong LD with the significantly associated SNPs. The QTL boundaries were defined as 292 
being the SNPs within a 5Mb window from the significantly associated SNPs that passed the 293 
LD threshold. In cases where QTL boundaries were overlapping, these QTL were merged and 294 
considered as a single (larger) QTL. 295 
Downstream Bioinformatic Analyses 296 
Once defined, the QTLs were subsequently mined for the presence of annotated candidate 297 
genes using Ensembl (https://www.ensembl.org/) based on the UMDv3.1 genome build. Only 298 
non-intergenic SNPs were considered for further analysis, i.e. SNPs with annotation 299 
information being one of the following: intron variant, splice donor variant, stop gained variant, 300 
missense variant, synonymous variant, downstream gene variant or upstream gene variant. 301 
Pathway analyses were then conducted based on these identified candidate genes using  302 
InnateDB (http://www.innatedb.com/) (Breuer et al., 2013), which utilized integrated pathway 303 
data from the Reactome Pathway Knowledgebase (https://reactome.org/) (Fabregat et al., 304 
2018), and the Pathway Interaction Database (Schaefer et al., 2009). The hypergeometric 305 
algorithm and Benjamini-Hochberg correction were used for querying InnateDB. 306 
RESULTS 307 
Variance components 308 
The prevalence of positive humoral response to MAP in the overall edited national cow data 309 
which included 136,767 cows was 4.0%; in the restricted cohort of 33,818 cows it was 7.7% 310 
and it ranged from 3.1% to 5.5% among the 8 different laboratories (Table 1). For the animal 311 
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models, heritability estimates ranged from 0.006 to 0.084 (Table 1); heritability estimates for 312 
the sire models ranged from 0.022 to 0.046. The heritability estimate for the overall population 313 
of 136,767 animals was 0.020 (SE = 0.003). The heritability estimate for the cohort of 33,818 314 
animals that were subsequently used for the genomic analysis was 0.050 (SE = 0.008). The 315 
additive genetic standard deviation for the prevalence of positive humoral response to MAP in 316 
the 10 (i.e., data from 8 laboratories and either the full or reduced dataset) different datasets 317 
ranged from 0.014 to 0.058 (Table 1). The additive genetic standard deviation for humoral 318 
response to MAP in the overall population was 0.027; the additive genetic standard deviation 319 
for the reduced cohort used for genomic analysis was 0.058. 320 
Estimated Breeding Values and their validation 321 
The mean EBV reliability of the 433,989 animals (i.e. the 33,818 with MAP humoral 322 
phenotypes and their 400,171 non-phenotyped relatives) was 0.089 (SD = 0.087). The EBV of 323 
individual animals ranged from -0.190 to 0.159; the maximum EBV reliability was 0.92. 324 
Considering only the cows that had their own MAP phenotype available (i.e. the restricted 325 
cohort of 33,818 cows), the mean EBV reliability was 0.192 (SD = 0.058). 326 
Summary statistics relating to the validation of EBVs are in Table 2. The raw mean 327 
prevalence of MAP in the poor, average and good EBV strata was 0.16, 0.14 and 0.12, 328 
respectively. The mean reliability of the EBVs was similar for each stratum (poor = 0.149, 329 
average = 0.144, good = 0.143). Stratum for MAP EBV was associated (p-value ≤0.001) with 330 
the logit of the probability of a positive MAP outcome; the area under the receiver operating 331 
curve when just MAP EBV stratum was included in the logistic regression was 0.539. 332 
Irrespective of whether only MAP stratum alone was included in the model or whether MAP 333 
stratum was also included simultaneously with other fixed effects, the poor EBV stratum had 334 
a greater (p-value <0.05) odds (1.37 to 1.43) of having a positive MAP outcome, relative to the 335 
good EBV stratum; although numerically worse, the odds of a positive MAP outcome in the 336 
animals within the average EBV stratum did not differ significantly from the good EBV 337 
stratum. The predicted probability of a positive MAP outcome in the poor, average and good 338 
EBV stratum for a third parity cow, 100 to 149 DIM, with no heterosis or recombination in the 339 
average herd-year was 0.134, 0.115 and 0.101, respectively. 340 
Genome-based associations and downstream bioinformatic analyses 341 
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A Manhattan plot depicting the association between each SNP and the deregressed EBV 342 
phenotype for MAP humoral response is presented in Figure 1. The present study identified 343 
223 SNPs as being associated (p-value ≤ 5 × 10-8) with MAP humoral response. A total of 344 
17,960 SNPs were identified as being in strong LD with these 223 SNPs, resulting in a total of 345 
18,181 SNPs considered as being associated with MAP humoral response. These SNPs resided 346 
within 47 QTL regions, which were distributed across 17 chromosomes namely BTA 1, 3, 5, 347 
6, 8, 9, 10, 11, 13, 14, 18, 21, 23, 25, 26, 27 and 29 (Table 3). The chromosome which harbored 348 
the most QTLs was BTA1 (10 QTLs), the largest of the QTLs being 6.87Mb in length. Mining 349 
these 47 QTL regions for SNP annotation data and candidate genes resulted in 623 positional 350 
candidate genes being identified for further investigation; further information on these findings 351 
can be found in Supplementary Table S1. Of the 623 genes, the majority (301) were on BTA 352 
18 (Table 3). The single QTL which harbored the most annotated positional candidate genes 353 
was on BTA 18 (from 53905719 – 61291660 bp; 243 genes), which contains genes such as 354 
PKD2, HIF3A and KLK1. 355 
The QTL that harbored the most genome-wide significantly associated SNPs was on 356 
BTA 1 (from 70108608 – 71811570 bp), with 65 SNPs identified and a further 14,543 in strong 357 
LD, and was 1.7 Mb long. The 5 most significantly associated SNPs with MAP resistance 358 
resided in a QTL upstream of the QTL which harboured the most significantly associated SNPs 359 
on BTA 1 (SNP genome-wide threshold p-value = 2.137x10-13) and all within a range of 16.7 360 
kb of each other. These SNPs were all mapped to the Kalirin (KALRN) gene; 4 were intronic 361 
variants (rs378864226, rs719379694, rs37959091, and rs384286217) and one was identified 362 
as a splice donor variant (rs378147396). Indeed, a variety of DNA variant annotations such as 363 
downstream variants, upstream variants, intronic variants, and splice region variants within the 364 
KALRN gene were significantly associated with MAP in the present study. 365 
In total, there were 22 positional candidate genes identified within the 47 QTL 366 
associated with MAP (Table 3), of which 10 were identified as potential functional candidate 367 
genes. Upon investigating the literature for potential biological functions of each, the most 368 
likely functional candidate genes identified along with KALRN, are Zinc Finger And BTB 369 
Domain Containing 20 (ZBTB20), lipoma-preferred partner (LPP), src-like-adapter 2 (SLA2), 370 
Coagulation factor XIII A chain (F13A1), leucine-rich repeats and calponin homology (CH) 371 
domain containing 3 (LRCH3), DnaJ Heat Shock Protein Family (Hsp40) Member C6 372 
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(DNAJC6), Zinc Finger DHHC-Type Containing 14 (ZDHHC14), sorting nexin-1 (SNX1) and 373 
hyaluronan synthase 2 (HAS2).  374 
Seventy-six distinct bovine biological pathways were initially identified using the list 375 
of 623 positional candidate genes. After applying the hypergeometric algorithm, 29 pathways 376 
had an unadjusted p-value <0.05 (Supplementary Table S2). After applying the Benjamini-377 
Hochberg correction, none of the pathways were identified as being enriched (minimum 378 
corrected p-value = 0.108). When known data on human biological pathways were included in 379 
the pathway analyses, 482 orthologous biological pathways were identified. Of these, 64 380 
pathways had an unadjusted p-value <0.05 (Supplementary Table S3). Once the Benjamini-381 
Hochberg adjustment was applied, none of the pathways were identified as being enriched 382 
(minimum corrected p-value = 0.239). 383 
 384 
DISCUSSION 385 
The challenges in addressing many cattle diseases, including bovine paratuberculosis, 386 
necessitates consideration of other disease mitigation strategies, one of which could be animal 387 
breeding. One of the advantages of breeding as a strategy to improve animal health is that it is 388 
cumulative and permanent with the genetic merit of a given animal being a function of all 389 
selection decisions made throughout its ancestral generations. Since in dairy cattle, the female 390 
must become pregnant to initiate a subsequent lactation, the marginal cost incurred to use 391 
superior germplasm semen is usually minimal. Given the detected existence of substantial 392 
genetic variation in humoral response to MAP in the present study, the justification for 393 
considering genetic merit for humoral response to MAP in a breeding program is therefore 394 
strong. This was substantiated by the exercise in the present study that validated MAP EBVs 395 
where a 1.43 greater odds of yielding a positive MAP result was detected in cows ranked poorly 396 
on genetic merit for MAP relative to their herd contemporaries ranked best on genetic merit 397 
for MAP. Twomey et al. (2016) undertook a similar EBV validation exercise based on cows 398 
divergent in parental average EBV for liver fluke. The area reported under the ROC reported 399 
by Twomey et al (2016) was 0.522, with cows in the top (i.e., worst) 10% being 1.28 (95% CI 400 
1.05 – 1.36) times more likely to have livers damaged by liver fluke, compared to 401 
contemporaries in the bottom (i.e. best) 10%. This difference in odds translated to a 6% unit 402 
probability difference between the top and bottom 10% of cows in the study cohort. Similarly, 403 
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using bovine tuberculosis (bTB) infection data in cattle, Ring et al. (2018 under review) 404 
reported a mean prevalence of 9.3% in cows in the worst 20% on parental EBV for bTB versus 405 
a mean prevalence of 6.9% in cows in the best 20% on parental EBV for bTB; this equated to 406 
an odds ratio of 1.44. The area under the ROC reported was 0.529 (95% CI 0.5236 – 0.5342) 407 
for the present study. These two validation studies, together with the results from the validation 408 
exercise in present study, clearly demonstrate the potential health gains achievable with genetic 409 
selection. While the mean EBV reliability of the validation cows in the present study was low 410 
(i.e., on average 0.145), further differentiative ability could have been achieved if the reliability 411 
of the EBV was greater. Such an increase in reliability could be achieved through access to 412 
more phenotypic data or the inclusion of genomic information in the prediction process 413 
(Meuwissen et al., 2001). Using the approach proposed by Wray et al. (2001), assuming a 414 
heritability of humoral response to MAP of 0.05 and a prevalence of 7.7%, the area under the 415 
ROC curve to predict the outcome for humoral response to MAP would increase from 0.56, if 416 
a only quarter of the genetic variance in the phenotype could be explained to 0.59 and 417 
eventually 0.63 if half and all of the genetic variance could be explained, respectively. 418 
A key question to be addressed in future studies is whether selecting for or against 419 
positive antibody response to MAP is beneficial for cattle populations. It could be surmised 420 
that selecting against positive antibody response is, in reality, selecting for the animals that can 421 
maintain a degree of internal cellular homeostasis despite having been infected by MAP. Such 422 
animals may in fact be shedding MAP, yet may not progress to the advanced clinical stages of 423 
bovine paratuberculosis. Irrespective, single trait selection for any trait is never recommended 424 
and thus any consideration of breeding for changes in the antibody response to MAP should be 425 
undertaken within the framework of a multi-trait breeding objective. 426 
 427 
Estimated variance components for MAP in comparison to previous studies 428 
Previous studies that estimated genetic parameters for paratuberculosis in cattle suggest 429 
heritability estimates of susceptibility to the disease range from <0.01 (Koets et al., 1999) to 430 
0.283 (Küpper et al., 2012); all studies to-date (which reported the actual breed of cattle used) 431 
have been undertaken in dairy cattle. A meta-analysis of the two available studies (Hinger et 432 
al., 2008, Berry et al., 2010) on dichotomized humoral response to MAP using blood ELISA 433 
and linear animal models, similar to the strategy adopted in the present study, resulted in a 434 
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pooled heritability estimate of 0.072 (pooled SE = 0.014); this was not very different to the 435 
0.05 (SE = 0.008) estimated in the present study. Once the prevalence of the previous estimates 436 
of heritability for dichotomized humoral response to MAP using ELISA were adjusted to a 437 
prevalence of 7.7%, as observed in the present study, the heritability on the underlying scale 438 
(Robertson and Lerner, 1949) varied from 0.19 (Hinger et al., 2008) to 0.34 (Berry et al., 2010), 439 
with an overall mean pooled heritability estimate of 0.234 for the two studies; the 440 
corresponding value for the present study was 0.17.  Neither the additive genetic standard 441 
deviation nor the residual standard deviation for the dichotomised humoral response to MAP 442 
were reported by Hinger et al. (2008) or Berry et al. (2010). As such, the additive genetic 443 
standard deviation and residual standard deviation in dichotomised humoral response to MAP 444 
infection reported in the present study cannot be compared. 445 
The heritability estimate for the humoral response to MAP infection using a sire model 446 
and the 33,818 cows in herds with at least 5 positive cows and at least one of those cows 447 
yielding a positive ELISA to MAP in the present study is of a similar magnitude of that reported 448 
by Kirkpatrick and Lett (2018). The range reported by Kirkpatrick and Lett (2018) using sire 449 
models and dichotomised humoral (or milk) antibody response to MAP was 0.041 (SE = 0.004) 450 
– 0.062 (SE = 0.007). The upper and lower limits of this range were based on cohorts of herds 451 
with at least one positive test (n = 999 sires represented by 222,872 daughter ELISA records) 452 
and ≥5% positive tests (n = 475 sires represented by 65,289 daughter ELISA records), 453 
respectively. Perhaps, as suggested by Kirkpatrick and Lett (2018), a sire threshold model 454 
analysis is a better analysis to conduct to gain an accurate estimate of the true heritability value 455 
for antibody responses to MAP infection. This approach may ameliorate the effects of the 456 
prevalence of MAP on a per-cohort basis on the estimates of heritability for dichotomized 457 
humoral response to MAP infection. When the heritability estimates for dichotomized antibody 458 
response to MAP using blood or milk ELISAs were adjusted to the prevalence reported in the 459 
present study (7.7%), the heritability on the underlying scale (Robertson and Lerner, 1949) 460 
varied from 0.14 – 0.21; the corresponding value for the present study was 0.16. 461 
The additive genetic standard deviation for humoral response to MAP was reported 462 
only by Gao et al. (2018), and was 0.125 which is considerably higher than the genetic standard 463 
deviation of 0.058 in the present study. The residual standard deviation (again, only reported 464 
by Gao et al. (2018)) was 0.55, compared to the lower estimate of 0.25 reported in the present 465 
study. Hence, the lower heritability reported in the present study could be attributed to a 466 
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relatively larger residual variance and lower genetic variance compared to other studies. 467 
Compounding this could be the fact that heritability estimate ranges reported in the present 468 
study on a per lab basis demonstrate site-specific levels of noise (i.e. residual variance). Noise 469 
could have been introduced in part due to environmental differences that existed between the 470 
laboratories, e.g. laboratory technicians at each laboratory could have possessed various levels 471 
of experience in conducting ELISAs. Furthermore, these assays may have been a routine 472 
procedure in some laboratories which specialize in such assays, whilst being an infrequent 473 
assay conducted in others. These factors, among others may have contributed to varying levels 474 
of residual variance being introduced on a per laboratory basis. Moreover, the somewhat low 475 
heritability estimate could also be attributed to the imperfect nature of ELISA tests in 476 
diagnosing cases and controls. Since ELISAs rely on the humoral response of individuals, they 477 
may not detect animals that are in the early stages of MAP infection, as they may not have 478 
mounted a humoral response to MAP infection at the point of testing (and may not for months, 479 
or even years); this results in infected animals being reported as ELISA negative to MAP, 480 
despite shedding MAP into the environment (Milner et al., 1987). False positive humoral 481 
results can also arise due to bTB infected animals, and bTB testing in herds prior to MAP 482 
testing without sufficient time elapsing between tests (i.e., 90 days) (Lilenbaum et al., 2007; 483 
Varges et al., 2009). Environmental mycobacteria (closely related to, but excluding MAP) 484 
could also potentially result in false positive ELISA results in the present study (Osterstock et 485 
al., 2007). As such, this misclassification introduces noise, thus biasing down heritability 486 
estimates (Milner et al., 1987, Bishop and Woolliams, 2010). 487 
Despite the relatively low heritability for humoral response to MAP in the present 488 
study, an accuracy of selection of 0.34 could be achieved with phenotypic information on just 489 
10 progeny; similarly, based on solely progeny phenotypes in a univariate genetic evaluation, 490 
MAP phenotypes on just 76 progeny would be required to achieve an accuracy of selection for 491 
humoral response to MAP of 0.70. High accuracy of selection is thus achievable in the presence 492 
of a national recording system for humoral response to MAP in cattle. 493 
Candidate genes associated with humoral response to MAP 494 
Of the 22 positional candidate genes identified in the 47 identified QTLs, ten were identified 495 
as potential functional candidate genes, based upon their gene ontology results and previous 496 
reports on their function in the literature (Bannantine and Bermudez, 2013, Liu et al., 2013, 497 
Marton et al., 2015). Some of these genes are novel in the sense that they have not previously 498 
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been associated with bovine paratuberculosis. The functional candidate genes of interest 499 
identified were KALRN, ZBTB20, LPP, SLA2, F13A1, LRCH3, DNAJC6, ZGHHC14, SNX1 500 
and HAS2; the (potential) biological functions of these are outlined below. All candidate genes 501 
have been shown to exhibit an expression profile in the bovine colon, duodenum, ileum, spleen 502 
and lymph nodes (Harhay et al., 2010). As stated by Brito et al. (2018), resistance or 503 
susceptibility to MAP infection appears to be a highly polygenic trait, reflecting the nature of 504 
bovine paratuberculosis, which is indeed, a highly complex trait. As such, the environmental 505 
influence on the manifestation of the trait must not be igrnoed. This influence may, in part, 506 
give rise to the fact that previous studies have implicated all bos Taurus autosomes as having 507 
an association with bovine paratuberculosis, yet there is little consistency observed among the 508 
reported genomic locations of these studies. Other factors which must be considered as 509 
contributors to this lack of coherence include the low heritability of the trait, inconsistent 510 
methods to classify MAP positive / negative animals, and divergent statistical methodologies 511 
employed on varying sample sizes of different cattle populations (Brito et al., 2018). Specific 512 
to the present study, another factor contributing to spurious results is the error in genotype 513 
imputation from sequence data. Despite the methods employed in the present study yielding a 514 
high imputation accuracy of 98%, the 2% error may have impacted upon the allele frequencies 515 
of the population, and thus the significance of some of the SNP associations obtained. 516 
Nevertheless, the results of the present study corroborate some previous findings in cattle, 517 
whilst some results are agree with those identified in human populations. 518 
KALRN. Gene ontology (GO) results for KALRN, found in a QTL on BTA1 (between 519 
positions 64369225 and 69754155), support it as a strong candidate gene influencing humoral 520 
response to MAP infection because of its role in encoding for the RhoGEF kinase protein. 521 
Human tissues such as the duodenum, colon, lymph nodes, small intestine and spleen have 522 
been reported to have expressed KALRN (Fagerberg et al., 2014), all of which are important in 523 
the pathology of Johne’s disease. Biological processes in which the RhoGEF kinase protein is 524 
involved include the positive regulation of Rho protein signal transduction as well as positive 525 
regulation of Rho GTPase activity. This is particularly interesting considering that the RhoA 526 
GTPase protein is located in intestinal epithelial cells and, upon stimulation by MAP, the 527 
bacteria infiltrates the intestinal submucosa (Bannantine and Bermudez, 2013). Infiltration of, 528 
and transcytosis through, the intestinal submucosa is crucial for MAP growth and replication, 529 
as it facilitates the bacterium crossing from the intestinal lumen to its target cells (i.e. 530 
macrophage and dendritic cells). From within macrophage and dendritic cells, MAP 531 
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successfully modulates the host’s immune responses, subverting immune attack. The 532 
intracellular subversion enables the bacterium to establish a niche within the host, providing it 533 
sufficient time to grow, replicate and spread through the surrounding intestines and lymph 534 
nodes (Bannantine and Bermudez, 2013, Arsenault et al., 2014, Koets et al., 2015). 535 
Furthermore, the rho kinase signal pathway has previously been implicated in inflammatory 536 
bowel disease (IBD) in humans, playing roles in intestinal barrier damage, abnormal immune 537 
response and intestinal fibrosis (Huang et al., 2015). Brito et al. (2018) also identified KALRN 538 
as a candidate gene in an independent population of ELISA-tested Canadian Holstein cattle. 539 
Given this, it is not unrealistic to hypothesize that KALRN plays an important role in the 540 
aforementioned processes in cattle susceptible to Johne’s disease. 541 
ZBTB20. Gene ontology results implicate the gene’s product in metal ion binding 542 
processes. The fact that MAP cannot endogenously produce mycobactin (necessary for iron 543 
transport), makes it an obligate intracellular parasite dependent upon the host for iron uptake 544 
and metabolism (Clark et al., 2008, McNees et al., 2015, Rathnaiah et al., 2017). Perhaps whilst 545 
subverting the host immune system inside target cells, MAP utilizes ZTBT20 to provide it with 546 
a means of exogenous iron to grow and replicate. The ZTBT20 gene has also been implicated 547 
in promoting toll-like receptor (TLR)-triggered innate immune responses in hosts via 548 
repressing the transcription of IκBα, which in turn promotes the activation of NFκB (Liu et al., 549 
2013). This corroborates the results of the gene-set enrichment analysis conducted by Kiser et 550 
al. (2017) in cattle, where enrichment analyses identified pathways involved with NFκB. TLRs 551 
have also been previously implicated in bovine paratuberculosis through candidate gene studies 552 
(Mucha et al., 2009; Koets et al., 2010). Expression of ZBTB20 has been observed in human 553 
tissues relevant to Johne’s disease such as the colon, duodenum, lymph nodes, small intestine 554 
and spleen (Fagerberg et al., 2014). Moreover, ZBTB20 was also identified as a candidate gene 555 
in the GWAS conducted by Brito et al. (2018) in dairy cows, further substantiating the evidence 556 
that ZBTB20 could indeed be associated with the resistance status of cattle to MAP. 557 
LPP. The potential role for LPP in the etiology of Johne’s disease could lie in the fact 558 
that it aids in signal transduction, cell migration, cytoskeletal remodeling and cell-cell adhesion 559 
(Jin et al., 2009). Although its exact function has yet to be established, LPP has been shown to 560 
enhance cell migration in response to cellular injury and has been linked to diseases such as 561 
atherosclerosis, a disorder which is characterized by an excessive chronic inflammatory 562 
immune response. Initially, this acute inflammatory response is beneficial in protecting the host 563 
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during immune challenges, but it becomes detrimental to the host when it turns chronic in 564 
nature (Ross and Agius, 1992). The chronicity of the inflammatory response causes the disease 565 
due to the fibroproliferative properties of the response resulting in granulomatous tissue (Ross 566 
and Agius, 1992; Kunkel et al., 1998). Perhaps what is an initial beneficial host immune 567 
response to MAP infection, progresses to become a chronic malignant over-activation of the 568 
host immune response. Coordinated in part by LPP, this response could result in the chronic 569 
granulomatous gastroenteritis characteristic of Johne’s disease. It could also be surmised that 570 
MAP uses LPP to intracellularly modulate macrophage lipoprotein metabolism for the benefit 571 
of the bacteria, whilst the recruitment of macrophages to the intestinal epithelium would 572 
maximize the bacteria’s opportunity to infiltrate host cells that enable it to grow and replicate. 573 
Human tissue expression studies report that LPP is expressed in the colon, duodenum, lymph 574 
nodes, small intestine and spleen (Fagerberg et al., 2014). 575 
SLA2. Gene ontology results for SLA2 includes T cell activation, which is an integral 576 
part of the host immune response. Src-like adaptor protein 2 (SLAP-2), encoded by SLA2, has 577 
been observed to be expressed in the small intestine, the colon, the spleen and the lymph nodes 578 
in humans (Fagerberg et al., 2014). As reviewed by Marton et al. (2015), the SLAP-2 protein 579 
negatively regulates the antigen receptor signaling action of both B and T lymphocytes, thus 580 
suppressing host immune responses. It has also been suggested that SLAP-2 is necessary for 581 
the maturation and activation of monocyte and dendritic cells (Liontos et al., 2011). Perhaps 582 
MAP modulates the expression of SLA2 within monocytes, thus subverting the host immune 583 
responses long enough for sufficient growth and replication to thrive. 584 
F13A1. Encoding for coagulation factor XIIIA, F13A1 is a strong candidate gene in the 585 
etiology of Johne’s disease as it promotes wound healing in damaged tissues, providing 586 
structural support and repaired vascularization. Coagulation factor XIIIA has also been 587 
implicated in IBD, as similar to atherogenesis, these initial beneficial mechanisms can in fact 588 
become detrimental to the host. The chronic inflammation observed in humans suffering from 589 
IBD is characterized by a hypercoagulable state accompanied by aberrations in coagulation 590 
processes (Danese et al., 2007). Mechanisms coordinated by coagulation factor XIII can cause 591 
increased neovascularization and impaired mucosal healing, which can cause additional 592 
inflammation in patients suffering from IBD (Gemmati et al., 2016). Genetic variation in 593 
F13A1 could result in susceptibility to Johne’s disease through abnormal coagulation 594 
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processes. The human colon, duodenum, lymph node, small intestine and spleen express F13A1 595 
(Fagerberg et al., 2014). 596 
LRCH3. Although there is a relative paucity of information in the literature regarding 597 
this gene, members of the leucine-rich repeat (LRR) family are thought to be critical in 598 
initiating inflammatory innate immune responses (Bell et al., 2003). Specifically, LRCH3, 599 
which is a member of this family, is a potential candidate gene involved in the pathology of 600 
Johne’s disease as it has previously been implicated in NFκB activation mechanisms in the 601 
NFκB immunoregulatory pathways (Gewurz et al., 2012). This evidence corroborates the 602 
aforementioned evidence of the gene-set enrichment analysis conducted by Kiser et al. (2017). 603 
Moreover, evidence in the literature has shown that LRCH3 is significantly differentially 604 
expressed between healthy colorectal tissue sample controls and samples presenting with 605 
colorectal cancer; the cancerous tissue samples exhibit a higher level of  LRCH3 expression 606 
(Piepoli et al., 2012). 607 
DNAJC6. The DnaJ Heat Shock Protein Family (Hsp40) Member C6 has been shown 608 
to be a useful biomarker in the design of predictive algorithms which classify the severity of 609 
IBD in patients to better diagnose and improve patient quality of life (Montero-Meléndez et 610 
al., 2013). Also known as PARK19, DNAJC6 has also been implicated in Parkinson’s disease 611 
(Ran & Belin, 2014). Following a review of the available literature, Dow (2014) hypothesised 612 
that there could indeed be a link between MAP and Parkinson’s disease in humans, a hypothesis 613 
which is yet to be confirmed.  614 
ZDHHC14. Zinc finger DHHC domain-containing 14 protein has been shown by Oo et 615 
al. (2014) to promote migration and invasion of scirrhous type gastric cancer, promoting 616 
tumour progression when overexpressed. The overexpression of this gene was significantly 617 
associated with scirrhous-patterning and the degree of the depth of cancer tumour invasion of 618 
gastric mucosa tissue collected from patients suffering from gastric cancer. As such, it is not 619 
unreasonable to hypothesise that ZDHHC14 plays a role in Johne’s disease, considering it is 620 
also a chronic, progressive disease of the gastrointestinal tract. 621 
SNX1. Downregulation of SNX1 has been linked to drug resistance in colorectal cancer, 622 
whilst also predicting poor prognosis for the disease (Bian et al., 2016). Specifically, the 623 
downregulation of SNX1 has been strongly associated with poor overall survival rate of patients 624 
suffering from colorectal cancer. Bian et al. (2016) hypothesised that upregulation of the gene 625 
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could provide a novel therapeutic intervention for this disease, an approach which could 626 
potentially be translated to veterinary medicine for the treatment of Johne’s disease in the 627 
future. Interestingly, there may be a synergy between the susceptible alleles for the 628 
aforementioned KALRN gene and the susceptible alleles for the SNX1 gene, as Prosser et al.  629 
(2010) have shown that SNX1 interacts with the Rac1 and RhoG guanine nucleotide exchange 630 
factor Kalirin-7; this process recruits the inactive Rho GTPase to its exchange factor, 631 
influencing cell membrane remodeling – perhaps a similar interaction occurs to initiate the 632 
process outlined above. 633 
HAS2. Upregulation of this gene, which produces hyaluronan synthesis, has been 634 
shown to be associated with IBD (among other inflammatory diseases), and has been shown to 635 
be expressed in human intestinal cells under the influence of the proinflammatory cytokine IL-636 
1beta (Ducale et al., 2005). In fact, Vigetti et al. (2010) demonstrated that in endothelial cells, 637 
monocyte adhesion depends strongly on hyaluronan. Throughout the inflammatory response, 638 
cells produce hyaluronan matrices, which in turn promote the adhesion of monocytes and 639 
macrophages to cell surfaces. This aids in the processes governing the transformation of 640 
macrophages in to foam cells, which contributes toward atherosclerotic plaque formations, very 641 
similar to F13A1 outlined above. Vigetti et al. (2010) also demonstrated that IL1-beta, and 642 
tumour necrosis factors alpha and beta strongly induce hyaluronan synthesis via the NFκB 643 
pathway, which again, was previously implicated in the pathology of Johne’s disease by Kiser 644 
et al., (2017). 645 
CONCLUSIONS 646 
Exploitable genetic variation in humoral response to MAP exists in the Holstein-Friesian 647 
population sampled in the present study. Thus, ample opportunity exists to capitalize on this 648 
variation through a breeding program for reduced MAP susceptibility. Moreover, the biological 649 
insights achieved from the identified QTLs and candidate genes provide novel evidence to 650 
support the notion that bovine paratuberculosis is molecularly similar to inflammatory bowel 651 
disease in humans; validation of the results reported herein are, nonetheless, crucial especially 652 
for the low MAF SNPs. Candidate genes and QTL regions reported within could also be used 653 
a priors in any further analyses, either association studies or genomic/phenotypic predictions 654 
that exploit Bayesian techniques. Furthermore, the results from the present study potentially 655 
enables researchers to gain a greater understanding of bovine paratuberculosis, and potential 656 
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therapeutic targets for future investigation, as breakthroughs in the treatment for inflammatory 657 
bowel disease may also be transferable to veterinary medicine. 658 
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Figure 1. Manhattan plot of the sequence GWAS using the deregressed estimated breeding values for humoral response to Mycobacterium avium 941 
subspecies paratuberculosis. These animals had an effective record contribution ≥1 (n = 1,883). Red threshold line = genome-wide significance 942 
(p-value ≤ 5 × 10-8), blue threshold line = suggestive SNPs (p-value ≤ 1 × 10-5). 943 
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Table 1. Summary statistics for Mycobacterium avium subspecies paratuberculosis infection 944 
for each cohort investigated. SE = standard error, σa = additive genetic standard deviation, (h2L) 945 
= transformed heritability on the liability scale. 946 
Cohort No. animals Prevalence 
(%) 
σa h2 (SE) h2L 
Entire dataseta 136,767 0.04 0.027 0.02 (0.003) 0.1014 
Entire datasets 136,767 (7,105 
sires) 
0.04 0.114 0.02 0.1132 
 
5 positive, 1 
homebreda 
33,818 0.077 0.058 0.05 (0.008) 0.1721 




0.077 0.057 0.046 0.1572 
Lab 1a 33,727 0.045 0.025 0.016 (0.005) 0.0770 
Lab 2 a 24,377 0.055 0.033 0.02 (0.008) 0.0937 
Lab 3 a 22,546 0.031 0.023 0.018 (0.006) 0.1141 
Lab 4 a 19,838 0.038 0.054 0.084 (0.013) 0.4536 
Lab 5 a 17,972 0.031 0.014 0.0063 (0.006) 0.0388 
Lab 6 a 5,433 0.055 0.021 0.009 (0.015) 0.0381 
Lab 7 a 10,197 0.029 0.018 0.012 (0.0095) 0.0731 
Lab 8 a 2,260 0.055 0.036 0.025 (0.032) 0.1039 
a = animal model used, s = sire model used. 947 
  948 
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Table 2 Summary statistics and odds ratios (95% confidence interval in parenthesis) for 949 














































Table 3 Quantitative trait loci (QTL) identified as being associated with humoral response to Mycobacterium avium subspecies paratuberculosis. 954 
Note, for cases where >1 single nucleotide polymorphism (SNP) possessed the same p-value but was associated with the same positional candidate 955 
gene, the first (position-wise) SNP was reported. MAF = minor allele frequency of the favourable allele. 956 


























1 26167312 26446316 4.129x10-8 C 0.005 0.007 26279218 intergenic  1 1 
1 28407185 28494094 1.483 x10-8 C 0.007 0.006 28407185 upstream ENSBTAG00000005101 1 1 
1 59604462 59612006 1.124x10-9 G 0.006 0.008 59612006 intron ZBTB20 1 1 
1 64369225 69754155 2.137x10-13 C 0.006 0.009 69624778 Intron KALRN 60 51 
1 69764180 69764180 3.433x10-9 T 0.012 0.005 69764180 Intron UMPS 1 1 
1 70108608 71811570 3.611x10-9 G 0.007 0.006 70854219 intron LRCH3 27 65 
1 79588937 79588937 1.723x10-9 A 0.006 0.011 79588937 Intron LPP 1 1 
1 80447980 80447980 3.651x10-8 C 0.007 0.005 80447980 intergenic - - 1 
1 88842592 88847970 1.679x10-9 G 0.006 0.010 88842592 intergenic - - 3 
1 112715335 119581742 5.777x10-12 A 0.006 0.012 113546452 intergenic - 40 10 
3 4670952 4670966 1.735x10-9 T 0.006 0.010 4670952 intergenic - - 3 
3 79626954 80275067 1.814x10-8 A 0.003 0.997 80275067 intron DNAJC6 5 2 
5 96254052 99194836 7.170x10-10 A 0.008 0.006 98598926 intergenic  28 2 
6 55845383 55845383 2.589X10-8 A 0.007 0.006 55845383 intergenic - - 1 
8 81381959 81857714 4.294x10-8 G 0.005 0.010 81782508 intergenic  2 2 
9 73680357 73821094 1.557x10-8 T 0.005 0.012 73726695 intergenic - - 1 
9 87476619 90634355 7.548x10-13 C 0.005 0.021 89425331 intergenic  27 2 
9 91561782 91571541 4.495x10-9 T 0.006 0.012 91571541 intergenic - - 1 
9 92215914 92215914 1.531x10-8 G 0.007 0.005 92215914 intergenic  - 1 
9 95503522 95897049 6.589x10-13 C 0.010 0.005 95619684 intron ZDHHC14 3 2 
10 44616944 48347572 3.683x10-8 G 0.006 0.010 45898484 downstream SNX1 35 1 
11 5908958 5908958 1.915x10-10 A 0.007 0.006 5908958 intron NPAS2 1 1 
11 6005215 6005215 8.296 x10-11 C 0.008 0.005 6005215 downstream NPAS2 1 1 
11 6150881 6150890 8.777 x10-11 T 0.008 0.005 6150881 intergenic  - 2 
11 6187500 6241603 1.568 x10-11 A 0.004 0.017 6227418 intron RNF149 2 1 
11 6327860 6327860 4.972 x10-8 G 0.006 0.007 6327860 intron RFX8 1 1 
34 
 
11 6333224 6333267 1.807 x10-8 G 0.003 0.030 6333255 intron RFX8 1 2 
11 9606899 9606899 1.246 x10-8 A 0.003 0.030 9606899 intron TACR1 1 1 
13 28234519 30909480 1.338 x10-8 A -0.007 0.005 29951397 intergenic  19 1 
13 62037755 62037755 1.942 x10-9 C 0.007 0.006 62037755 intron XKR7 1 1 
13 66373805 66373805 6.292 x10-10 T 0.006 0.008 66373805 intron SLA2 1 1 
13 70488028 72329336 2.910 x10-8 A 0.003 0.027 72023756 intergenic  12 1 
14 16944837 21128294 2.276 x10-8 A 0.006 0.008 19711487 intron HAS2 32 1 
14 33563774 33601252 3.990 x10-8 T -0.001 0.297 33588051 intron CPA6 1 1 
18 50390456 52265553 2.677 x10-11 G 0.007 0.009 51899478 intron TEX101 58 28 
18 53905719 61291660 3.048 x10-11 A 0.009 0.005 61212502 intron ENSBTAG00000040392 243 7 
21 62644820 62644820 1.414 x10-8 G 0.005 0.013 62644820 intergenic - - 1 
23 46741649 46741649 3.792 x10-8 A 0.003 0.040 46741649 intergenic - - 1 
23 48411393 48482001 3.669 x10-8 T 0.006 0.009 48460057 intergenic  1 1 
23 48741897 48741897 5.799 x10-9 T 0.007 0.006 48741897 intron F13A1 1 1 
23 49577226 49659683 2.135 x10-8 T 0.006 0.009 49577226 intron CDYL 1 1 
25 5454814 5454814 9.015 x10-9 T 0.006 0.012 5454814 intergenic  - 1 
25 32829869 32829869 1.277 x10-9 T 0.004 0.024 32829869 intergenic  - 1 
26 7959610 7959610 3.889 x10-9 C 0.005 0.012 7959610 intron PRKG1 1 1 
27 6246011 6544550 1.185 x10-8 A 0.004 0.018 6544550 intergenic  2 1 
29 31234645 31234645 1.608 x10-8 T 0.006 0.008 31234645 intergenic   1 











Supplementary Table S1. All positional candidate genes residing within the 47 quantitative trait loci (QTL) that harbor the SNPs that passed the 965 
genome-wide significance threshold of 5 x 10-8. Cases where there was no candidate genes identified are denoted with a dash (-). 966 







1 26167312 26446316 1(3) ROBO1 
1 28407185 28494094 1(1) ENSBTAG00000005101 
1 59604462 59612006 1(1) ZBTB20 
1 64369225 69754155 51(1038) IGSF11,ENSBTAG00000014157,UPK1B,B4GALT4,ARHGAP31,TMEM39A,POGLUT1,TIMMDC1,CD80,ADPRH,PLA1A,POPDC2, 
COX17,MAATS1,SNORA31,NR1I2,ENSBTAG00000040597,ENSBTAG00000048057,GPR156,LRRC58,FSTL1, 
ENSBTAG00000015892,HGD,RABL3,GTF2E1,STXBP5L,POLQ,ARGFX,FBXO40,HCLS1,GOLGB1,IQCB1,EAF2,SLC15A2,ENSBTAG0
0000001442,ILDR1,CD86,ENSBTAG00000003865,7SK,ENSBTAG00000014133,CSTA,CCDC58,KPNA1, PARP9, DTX3L, 
PARP14,HSPBAP1,DIRC2,SEMA5B,PDIA5,SEC22A,ADCY5,5S_rRNA,HACD2,ENSBTAG00000023608,MYLK,CCDC14,ENSBTAG000
00006947,KALRN,UMPS 
1 69764180 69764180 1(0) UMPS 
1 70108608 71811570 65(14543) HEG1,SLC12A8,ZNF148,SNX4,OSBPL11,ENSBTAG00000003383,LMLN,ENSBTAG00000014208,IQCG,LRCH3,FYTTD1,RUBCN,MUC
20,ENSBTAG00000014721,TNK2,TFRC,ZDHHC19,SLC51A,PCYT1A,ENSBTAG00000032684,ENSBTAG00000040161,UBXN7,ENSBTA
G00000013317,SMCO1,WDR53,FBXO45,NRROS 
1 79588937 79588937 1(0) LPP 
1 80447980 80447980 1(0) - 
1 88842592 88847970 3(6) - 




3 4670952 4670966 3(6) - 
3 79626954 80275067 2(6) PDE4B,ENSBTAG00000030852,LEPR,LEPROT,DNAJC6 






6 55845383 55845383 1(0) - 
8 81381959 81857714 2(8) GAS1, SNORA70 
9 73680357 73821094 1(0) - 
9 87476619 90674280 2(131) TAB2,ZC3H12D,PPIL4,GINM1,KATNA1,LATS1,NUP43,PCMT1,LRP11,RAET1G,ENSBTAG00000038891,ENSBTAG00000024751,ENS
BTAG00000036061,ENSBTAG00000039875,PPP1R14C,IYD,PLEKHG1,MTHFD1L,AKAP12,bta-mir2285e2, ZBTB2, RMND1, 
ARMT1,TOMM7,CCDC170,ESR1,SYNE1 
9 91561782 91571541 1(0) - 
9 92215914 92215914 1(0) - 
9 95503522 95897049 2(1) ZDHHC14, 7SK, SNX9 
10 44616944 48347572 1(0) FRMD6,GNG2,C14orf166,NID2,ENSBTAG00000001423,PTGDR,PLEKHO2,PIF1,RBPMS2,OAZ2,ZNF609,TRIP4,ENSBTAG000000394
62,CSNK1G1,PPIB,SNX22,SNX1,FAM96A,DAPK2,HERC1,FBXL22,USP3,CA12,APH1B,RAB8B,ENSBTAG00000012898,LACTB,TPM1,
TLN2,bta-mir-190a,ENSBTAG00000020814,SNORA2,U6,ENSBTAG00000010952,VPS13C 
11 5908958 5908958 1(0) NPAS2 
11 6005215 6005215 1(0) NPAS2 
11 6150881 6150890 2(2) - 
11 6187500 6241603 1(0) CNOT11, RNF149 
11 6327860 6327860 1(0) RFX8 
11 6333224 6333267 2(6) RFX8 
11 9606899 9606899 1(0) TACR1 
13 28234519 30909480 1(0) ENSBTAG00000007700,SEPHS1,BEND7,ENSBTAG00000017244,FRMD4A,ENSBTAG00000010023,CDNF,HSPA14,SUV39H2,DCLRE
1C,MEIG1,OLAH,ACBD7,RPP38,NMT2,FAM171A1,U6,ITGA8,FAM188A 
13 62037755 62037755 1(0) XKR7 
13 66373805 66373805 1(0) SLA2 
13 70488028 72329336 1(0) U6,ENSBTAG00000046785,PLCG1,ZHX3,ENSBTAG00000045671,LPIN3,EMILIN3,CHD6,bta-mir-544b-1, ENSBTAG00000048055, 
ENSBTAG00000046673,ENSBTAG00000000309 






14 33563774 33601252 1(0) CPA6 
































21 62644820 62644820 1(0) - 
23 46741649 46741649 1(0) - 
23 48411393 48482001 1(0) LY86 
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23 48741897 48741897 1(0) F13A1 
23 49577226 49659683 1(0) CDYL 
25 5454814 5454814 1(0) - 
25 32829869 32829869 1(0) - 
26 7959610 7959610 1(0) PRKG1 
27 6246011 6544550 1(0) GPM6A, ENSBTAG00000046071 
29 31234645 31234645 1(0) - 
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Supplementary Table S2 Bovine biological pathways with an unadjusted p-value <0.05 identified (n = 29). Pathway Id relates to the 971 
corresponding Reactome pathway ID. 972 
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Antigen activates B Cell Receptor (BCR) leading to 
generation of second messengers 
19637 2 0.004222589 0.320916736 CALM; CD79A; 
ADP signalling through P2Y purinoceptor 1 18736 2 0.006249223 0.158313652 GNG2; P2RY1; 
Activation of Kainate Receptors upon glutamate binding 16714 2 0.006249223 0.158313652 CALM; GNG2; 
Signal amplification 18462 2 0.011356063 0.215765188 GNG2; P2RY1; 
Eukaryotic Translation Termination 19690 5 0.013724741 0.208616057 RPL13A; RPL18; RPL35A; RPS11; RPS19; 
Peptide chain elongation 17599 5 0.014553831 0.184348521 RPL13A; RPL18; RPL35A; RPS11; RPS19; 
Nonsense Mediated Decay (NMD) independent of the 
Exon Junction Complex (EJC) 
17994 5 0.015416329 0.167377286 RPL13A; RPL18; RPL35A; RPS11; RPS19; 
Eukaryotic Translation Elongation 19898 5 0.016312806 0.154971658 RPL13A; RPL18; RPL35A; RPS11; RPS19; 
Formation of a pool of free 40S subunits 18106 5 0.020249388 0.170994831 RPL13A; RPL18; RPL35A; RPS11; RPS19; 
Nonsense Mediated Decay (NMD) enhanced by the 
Exon Junction Complex (EJC) 
17605 5 0.021323786 0.147327973 RPL13A; RPL18; RPL35A; RPS11; RPS19; 
Nonsense-Mediated Decay (NMD) 19399 5 0.021323786 0.147327973 RPL13A; RPL18; RPL35A; RPS11; RPS19; 
Metabolism of nitric oxide 17490 2 0.021428562 0.125274669 CALM; NOSIP; 
eNOS activation and regulation 17377 2 0.021428562 0.125274669 CALM; NOSIP; 
Transmission across Chemical Synapses 17968 4 0.025563686 0.138774297 AP2S1; CALM; GNG2; SLC17A7; 
SRP-dependent cotranslational protein targeting to 
membrane 
16985 5 0.025996652 0.13171637 RPL13A; RPL18; RPL35A; RPS11; RPS19; 
Metabolism of proteins 18621 10 0.028395646 0.13487932 LHB; PDIA5; PLAUR; RPL13A; RPL18; RPL35A; RPS11; 
RPS19; SAE1; SERP1; 
GTP hydrolysis and joining of the 60S ribosomal 
subunit 
18494 5 0.028564244 0.127698973 RPL13A; RPL18; RPL35A; RPS11; RPS19; 
Platelet homeostasis 18659 2 0.029589522 0.124933536 GNG2; PRKG1; 
L13a-mediated translational silencing of Ceruloplasmin 
expression 
17580 5 0.029907203 0.119628811 RPL13A; RPL18; RPL35A; RPS11; RPS19; 
Ca2+ pathway 18159 2 0.034064589 0.117677671 CALM; GNG2; 
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IRE1alpha activates chaperones 18497 2 0.034064589 0.117677671 PDIA5; SERP1; 
XBP1(S) activates chaperone genes 18959 2 0.034064589 0.117677671 PDIA5; SERP1; 
Cap-dependent Translation Initiation 17876 5 0.034176885 0.108226802 RPL13A; RPL18; RPL35A; RPS11; RPS19; 
Eukaryotic Translation Initiation 17853 5 0.034176885 0.108226802 RPL13A; RPL18; RPL35A; RPS11; RPS19; 
Hemostasis 17834 7 0.03588147 0.109079669 CALM; F13A1; GNG2; LOC512741; P2RY1; PLAUR; 
PRKG1; 
Inactivation, recovery and regulation of the 
phototransduction cascade 
19685 2 0.038786223 0.113375113 CALM; NMT2; 
Neuronal System 18958 4 0.042031414 0.118310647 AP2S1; CALM; GNG2; SLC17A7; 
The phototransduction cascade 17305 2 0.043742531 0.118729728 CALM; NMT2; 
Neurotransmitter Receptor Binding And Downstream 
Transmission In The  Postsynaptic Cell 




Supplementary Table S3 Biological pathways using human ortholog data with an unadjusted p-value <0.05 identified (n = 64). Pathway Id relates 974 
to the corresponding Reactome pathway ID. 975 
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Inwardly rectifying K+ channels 18309 5 6.39E-04 0.308173259 BT.62324; GNG2; GNG8; KCNJ1; KCNJ5; 
Neuronal System 17312 14 0.002257084 0.543957324 ADCY5; AP2A1; BT.62324; GNG2; GNG8; GRIK5; 
GRIN2D; KCNA7; KCNC3; KCNJ1; KCNJ5; PPFIA3; 
RRAS; SLC17A7; 
AKT phosphorylates targets in the 
cytosol 
12988 3 0.002500313 0.301287698 BT.52156; CDKN1B; GSK3A; 
DNA-PK pathway in nonhomologous 
end joining 
15829 3 0.002500313 0.301287698 DCLRE1C; PNKP; PRKDC; 
Thromboxane A2 receptor signaling 14941 4 0.00266897 0.257288669 ARHGEF1; BT.45031; GNG2; PTGDR; 
Hyaluronan biosynthesis and export 13620 2 0.003284616 0.263864138 BT.63577; HAS1; 
Golgi Associated Vesicle Biogenesis 13839 5 0.004965629 0.341918993 BT.65042; FTL; NAPA; SNX9; TFRC; 
G alpha (s) signalling events 13224 8 0.005154194 0.310540179 ADCY5; BT.45031; GNG2; GNG8; LHB; PDE4B; 
PTGDR; PTH2; 
Nef Mediated CD8 Down-regulation 13682 2 0.00538863 0.288591092 AP2A1; AP2S1; 
Arf1 pathway 15337 3 0.005933294 0.285984751 AP2A1; CYTH2; KDELR1; 
Potassium Channels 18590 7 0.00737954 0.323358022 BT.62324; GNG2; GNG8; KCNA7; KCNC3; KCNJ1; 
KCNJ5; 
Neurotransmitter Receptor Binding And 
Downstream Transmission In The  
Postsynaptic Cell 
19389 8 0.00738831 0.296763794 ADCY5; AP2A1; GNG2; GNG8; GRIK5; GRIN2D; 
KCNJ5; RRAS; 
Transmission across Chemical Synapses 18918 10 0.007610675 0.282180407 ADCY5; AP2A1; GNG2; GNG8; GRIK5; GRIN2D; 
KCNJ5; PPFIA3; RRAS; SLC17A7; 
FOXM1 transcription factor network 15700 4 0.008284666 0.285229223 BT.32558; GAS1; GSK3A; XRCC1; 
Base Excision Repair 18332 3 0.008348716 0.251505076 LIG1; POLD1; XRCC1; 
Resolution of Abasic Sites (AP sites) 17264 3 0.008348716 0.251505076 LIG1; POLD1; XRCC1; 
Clathrin derived vesicle budding 13840 5 0.008958367 0.239885156 BT.65042; FTL; NAPA; SNX9; TFRC; 
trans-Golgi Network Vesicle Budding 16988 5 0.008958367 0.239885156 BT.65042; FTL; NAPA; SNX9; TFRC; 
Prostacyclin signalling through 
prostacyclin receptor 
13104 3 0.009742664 0.247156012 BT.45031; GNG2; GNG8; 
Sema4D mediated inhibition of cell 
attachment and migration 
13907 2 0.010965481 0.264268088 ARHGAP35; RRAS; 
Activation of GABAB receptors 17880 4 0.012251089 0.268410216 ADCY5; GNG2; GNG8; KCNJ5; 
GABA B receptor activation 13345 4 0.012251089 0.268410216 ADCY5; GNG2; GNG8; KCNJ5; 
Glycosphingolipid biosynthesis 552 3 0.012914624 0.270645607 B4GALT4; BT.21655; FUT1; 
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Influenza Infection 16853 7 0.013740425 0.275953543 KPNA1; NUP43; RPL13A; RPL35A; RPS11; RPS19; 
TGFB1; 
Nef Mediated CD4 Down-regulation 13684 2 0.014393004 0.277497116 AP2A1; AP2S1; 
Ctcf: first multivalent nuclear factor 4040 3 0.01469612 0.272443457 CD79A; CDKN1B; TGFB1; 
Class I PI3K signaling events mediated 
by Akt 
15022 3 0.016609692 0.285923987 CDKN1B; KPNA1; PRKDC; 
PAR1-mediated thrombin signaling 
events 
15229 3 0.016609692 0.285923987 ARHGEF1; GNG2; SNX1; 
Prostanoid ligand receptors 13236 2 0.018217734 0.302791305 BT.45031; PTGDR; 
ADP signalling through P2Y 
purinoceptor 1 
13119 3 0.018656228 0.272493999 GNG2; GNG8; P2RY1; 
Activation of G protein gated Potassium 
channels 
13351 3 0.018656228 0.272493999 GNG2; GNG8; KCNJ5; 
G protein gated Potassium channels 17648 3 0.018656228 0.272493999 GNG2; GNG8; KCNJ5; 
Inhibition  of voltage gated Ca2+ 
channels via Gbeta/gamma subunits 
13344 3 0.018656228 0.272493999 GNG2; GNG8; KCNJ5; 
Sema4D in semaphorin signaling 13909 3 0.020836309 0.29538532 ARHGAP35; MYH14; RRAS; 
Retrograde neurotrophin signalling 13194 2 0.022419003 0.308741692 AP2A1; AP2S1; 
Adrenaline,noradrenaline inhibits insulin 
secretion 
13553 3 0.023150227 0.309955819 ADCY5; GNG2; GNG8; 
Activation of Kainate Receptors upon 
glutamate binding 
18335 3 0.025598005 0.324690486 GNG2; GNG8; GRIK5; 
Extension of Telomeres 19607 3 0.025598005 0.324690486 LIG1; POLD1; RUVBL2; 
Processive synthesis on the C-strand of 
the telomere 
12917 2 0.02697689 0.333406698 LIG1; POLD1; 
Opioid Signalling 13260 5 0.029702303 0.35791275 ADCY5; GNG2; GNG8; PDE4B; PPP2R1A; 
GABA receptor activation 17604 4 0.030698604 0.360895788 ADCY5; GNG2; GNG8; KCNJ5; 
Platelet homeostasis 13108 5 0.031261582 0.358763874 BT.45031; GNG2; GNG8; PPP2R1A; SLC8A2; 
Carm1 and regulation of the estrogen 
receptor 
4134 2 0.031872206 0.349145529 BT.32558; GTF2E1; 
Non-homologous end-joining 2800 2 0.031872206 0.349145529 DCLRE1C; PRKDC; 
Glucagon signaling in metabolic 
regulation 
13556 3 0.036719604 0.384757592 ADCY5; GNG2; GNG8; 
Signal amplification 19554 3 0.036719604 0.384757592 GNG2; GNG8; P2RY1; 
Syndecan-1-mediated signaling events 15809 2 0.037086461 0.372409876 PPIB; TGFB1; 
WNT5A-dependent internalization of 
FZD4 
16977 2 0.037086461 0.372409876 AP2A1; AP2S1; 
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Influenza Life Cycle 19285 6 0.037542603 0.369296625 KPNA1; NUP43; RPL13A; RPL35A; RPS11; RPS19; 
Base excision repair 2819 3 0.039828675 0.383948427 LIG1; POLD1; XRCC1; 
Canonical Wnt signaling pathway 15524 2 0.042601847 0.354036042 CSNK1G1; LRP6; 
Eicosanoid ligand-binding receptors 13238 2 0.042601847 0.354036042 BT.45031; PTGDR; 
Glycosphingolipid biosynthesis 565 2 0.042601847 0.354036042 BT.21655; FUT1; 
Hyaluronan metabolism 19552 2 0.042601847 0.354036042 BT.63577; HAS1; 
Mismatch repair (MMR) directed by 
MSH2:MSH3 (MutSbeta) 
19229 2 0.042601847 0.354036042 LIG1; POLD1; 
Mismatch repair (MMR) directed by 
MSH2:MSH6 (MutSalpha) 
18261 2 0.042601847 0.354036042 LIG1; POLD1; 
Processive synthesis on the lagging 
strand 
12950 2 0.042601847 0.354036042 LIG1; POLD1; 
Termination of O-glycan biosynthesis 13367 2 0.042601847 0.354036042 MUC20; MUC4; 
Telomere Maintenance 17962 3 0.043066945 0.35183504 LIG1; POLD1; RUVBL2; 
Nonsense Mediated Decay (NMD) 
enhanced by the Exon Junction Complex 
(EJC) 
13341 5 0.045581053 0.36016504 PPP2R1A; RPL13A; RPL35A; RPS11; RPS19; 
Nonsense-Mediated Decay (NMD) 16937 5 0.045581053 0.36016504 PPP2R1A; RPL13A; RPL35A; RPS11; RPS19; 
NGF signalling via TRKA from the 
plasma membrane 
18753 8 0.045937984 0.35713078 ADCY5; AP2A1; AP2S1; BT.52156; CDKN1B; GSK3A; 
PLCG1; PPP2R1A; 
Mismatch Repair 19342 2 0.048401218 0.370307735 LIG1; POLD1; 
Signaling by EGFR 13216 7 0.049612884 0.373647035 ADCY5; AP2A1; AP2S1; BT.52156; CDKN1B; GSK3A; 
PLCG1; 
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